진해제 시장 : 약제 클래스별, 투여 경로별, 연령대별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Antitussive Drugs Market with COVID-19 Impact Analysis, By Drug Class, By Route of Administration, By Age Group, By End-Users, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

US $ 3,250 ￦ 4,535,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650 ￦ 6,488,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650 ￦ 7,884,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

보고서 주요 내용

진해제 시장 규모는 2022년 14억 830만 달러로 2023년부터 2030년까지 CAGR 5.1%로 확대

진해제 시장 - 시장 역학:

• 기침 환자의 증가와 노령 인구의 증가는 시장 성장을 증가시킬 것입니다.
• 진해제 수요를 증가시키는 주요 요인은 기침이며, 이는 시장 성장을 주도합니다. 또한 호흡기 질환의 유병률 증가와 높은 대기 오염으로 인해 개인의 기침 사례가 증가하고 있습니다. 사람들의 기침과 기침의 전염성은 전 세계 일차 진료 의사를 방문하는 가장 일반적인 목적입니다. 이처럼 지속적인 기침은 사람의 삶의 질을 떨어뜨릴 수 있기 때문에 진해제에 대한 수요는 꾸준히 증가할 것으로 보입니다. 그러나 높은 가격의 진해제 가격과 신흥국 시장의 의료 인프라 부족이 시장 수요를 저해할 것으로 예상됩니다. 또한, 노인들은 만성 질환에 걸리기 쉬워 시장 성장률을 가속화할 것으로 예상됩니다. 따라서 노인 인구의 증가가 시장을 견인할 것으로 예상됩니다.

진해제 시장 - 세분화 분석:

• 세계 진해제 시장은 약제 클래스별, 투여 경로별, 연령대별, 최종사용자별, 지역별로 세분화됩니다.
• 약물 종류별로는 말초 작용제, 중추 작용제, 기타로 분류됩니다. 중추성 약물 부문은 예측 기간 동안 우위를 유지할 것으로 보입니다. 중추성 약물은 기침 중추를 표적으로 삼아 뇌에 작용하여 기침 충동을 최소화합니다. 또한, 이러한 약물은 점액을 생성하지 않는 지속적인 마른 기침을 치료하는 데 선호됩니다. 시장 성장의 원동력은 의약품 개발의 발전, 의료 정책의 변화, 호흡기 질환의 유행, 일반의약품 및 처방약에 대한 소비자 선호도 등이 있습니다.
• 시장은 투여 경로에 따라 흡입, 경구 및 기타 두 가지 범주로 나뉩니다. 경구제가 가장 높은 시장 점유율을 차지할 것으로 예상됩니다. 경구 부문은 정제, 가글액, 시럽제, 캡슐제 등 전체 경구용 진해제 시장 중 특정 부문에 대한 시장 평가 및 분석을 의미합니다.
• 시장은 연령대에 따라 노인, 소아, 성인 등 세 가지로 분류됩니다. 고령자 부문은 빠른 성장이 예상됩니다. 노인 인구는 65세 이상을 의미합니다. 노인 인구는 특별한 의료 수요와 특성을 가지고 있으며, 의약품, 의료 등 여러 산업에 영향을 미칩니다.
• 시장은 최종사용자에 따라 홈케어, 병원, 전문 클리닉 및 기타 세 가지 범주로 나뉩니다. 가장 큰 시장 점유율을 차지하는 것은 전문 클리닉입니다. 이 부문은 호흡기내과, 호흡기내과 등 특정 의료 전문 분야에 초점을 맞추고 있습니다. 전문 클리닉은 일반적으로 호흡기 질환에 대한 임상시험 및 연구에 참여합니다. 또한 새로운 진해제를 시험하고 개발하는 데 도움이 됩니다.

진해제 시장 - 지리적 인사이트:

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카로 나뉩니다. 이들 지역은 사업 운영 국가에 따라 더욱 세분화됩니다.

진해제 시장 - 경쟁 상황:

진해제의 접근성과 인지도 향상은 시장 성장에 유리합니다. 또한, 공공 기관과 민간 단체가 인지도 확산을 위한 이니셔티브를 취함으로써 진해제 시장은 활기를 띌 것으로 보입니다. 상기도 감염의 증가와 가처분 소득의 증가는 진해제 사업의 확장을 가져올 것입니다. 연구개발 활동의 증가는 유익한 기회를 제공하는 동시에 의약품 출시 및 승인 증가는 시장 성장률을 더욱 높일 것으로 보입니다. 예를 들어, 2021년 3월 머크는 미국 식품의약국(FDA)과 경구용 선택적 P2X3 수용체 길항제이자 비마약성 약물인 gefapixant의 신약승인신청(NDA)에 대한 다음 단계를 논의할 예정입니다. )에 대해 다음 단계 논의를 위한 심사 완료 보고서(CRL)를 발행했다고 밝혔습니다.

목차

제1장 진해제 시장 개요

• 조사 범위
• 시장 추정 연수

제2장 주요 요약

• 시장 내역
• 경쟁 인사이트

제3장 진해제 주요 시장 동향

• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 향후 시장 동향

제4장 진해제 업계 조사

• PEST 분석
• Porter's Five Forces 분석
• 성장 전망 매핑
• 규제 체계 분석

제5장 진해제 시장 : COVID-19의 영향 분석

• 신종 코로나바이러스 감염증 이전의 영향 분석
• 신종 코로나바이러스 감염증 후의 영향 분석

제6장 진해제 시장 상황

• 진해제 시장 점유율 분석, 2022년
• 주요 제조업체별 내역 데이터
  • 기존 기업 분석
  • 신흥 기업 분석

제7장 진해제 시장 - 약제 클래스별

• 개요
  • 약제 클래스별 부문 점유율 분석
  • 말초 작용약
  • 중추 작용약
  • 기타

제8장 진해제 시장 - 투여 경로별

• 개요
  • 투여 경로별 부문 점유율 분석
  • 흡입용
  • 어랄
  • 기타

제9장 진해제 시장 - 연령층별

• 개요
  • 연령층별 부문 점유율 분석
  • 고령자용
  • 소아
  • 성인

제10장 진해제 시장 - 최종사용자별

• 개요
  • 최종사용자별 부문 점유율 분석
  • 홈케어
  • 병원
  • 전문 클리닉
  • 기타

제11장 진해제 시장 - 지역별

• 서론
• 북미
  • 개요
  • 북미의 주요 제조업체
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 유럽의 주요 제조업체
  • 독일
  • 이탈리아
  • 영국
  • 프랑스
  • 러시아
  • 네덜란드
  • 스웨덴
  • 폴란드
  • 기타
• 아시아태평양(APAC)
  • 개요
  • 아시아태평양의 주요 제조업체
  • 인도
  • 중국
  • 일본
  • 한국
  • 호주
  • 태국
  • 인도네시아
  • 필리핀
  • 기타
• 라틴아메리카
  • 개요
  • 라틴아메리카의 주요 제조업체
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
  • 기타
• 중동 및 아프리카
  • 개요
  • 중동 및 아프리카의 주요 제조업체
  • 사우디아라비아
  • 아랍에미리트
  • 이스라엘
  • 터키
  • 알제리
  • 이집트
  • 기타

제12장 주요 벤더 분석 - 진해제 업계

• 경쟁 대시보드
• 기업 개요
  • Teva Pharmaceutical Industries Ltd.
  • Intas Pharmaceuticals Ltd.
  • Bayer AG
  • Aceto
  • Sanofi
  • Ipca Laboratories Ltd.
  • 3M
  • F. Hoffmann-La Roche Ltd.
  • Hikma Pharmaceuticals PLC
  • Unique Pharmaceuticals Limited
  • Cipla Inc.
  • Mylan NV
  • Zydus Cadila
  • Sanofi
  • Novartis AG
  • Aurobindo Pharma

제13장 애널리스트의 전방위 전망

ksm

영문 목차

영문목차

REPORT HIGHLIGHT

Antitussive drugs market size was valued at USD 1,408.3 Million in 2022, expanding at a CAGR of 5.1% from 2023 to 2030.

Antitussive drugs are defined as heterogeneous medications commonly used in patients suffering from respiratory disorders to suppress dry cough. In addition, various symptoms caused by common allergies, colds, flu, hay fever, or other breathing disorders like bronchitis and sinusitis can be treated by antitussive drugs. These drugs act on the cough center in the brain to reduce the urge to cough in patients. They are either opioids or opiates such as dextromethorphan, pholcodine, and codeine. Moreover, one of the commonly used drugs is dextromethorphan over-the-counter antitussive drugs, and it is relatively safe.

Antitussive Drugs Market- Market Dynamics:

• Rising cough cases and the geriatric population will augment the market growth.

• The major element boosting demand for antitussive drugs is cough, which will drive the market growth. In addition, the growing prevalence of respiratory disorders and the high rate of atmospheric pollution increase the cases of cough in individuals. The contagious nature of people's coughs and coughs is the most common purpose to visit primary care physicians across the world. Thus, persistent cough can harm a person's quality of life; the demand for antitussive drugs will witness steady growth. However, the high cost of antitussive drugs and the lack of healthcare infrastructure in developing nations are expected to hamper the market demand. Furthermore, the older population is more prone to chronic disease, which is anticipated to accelerate the market's growth rate. Thus, the rise in the geriatric population will be projected to drive the market forward.

Antitussive Drugs Market- Key Insights:

• As per the analysis shared by our research analyst, the global antitussive drugs market is estimated to grow annually at a CAGR of around 5.1% over the forecast period (2023-2030)

• The antitussive drugs industry has been witnessing steady growth due to the widespread occurrence of cough-related conditions, including respiratory infections, allergies, and chronic obstructive pulmonary disease (COPD). The demand for antitussive medications tends to spike during flu and cold seasons.

• Based on drug class form segmentation, Centrally Acting Drugs was predicted to show promising market share in the year 2022

• Some antitussive medications are combined with other active ingredients, such as decongestants or expectorants, to provide comprehensive relief from multiple cold and flu symptoms.

Antitussive Drugs Market- Segmentation Analysis:

• The Global antitussive drugs market is segmented on the basis of drug class, route of administration, age group, end-users, and region.

• The market is divided into two categories based on drug class: peripherally acting drugs, centrally acting drugs, and others. The centrally acting drugs segment is likely to maintain its dominance over the forecast period. It works in the brain by targeting the cough center, minimizing the urge to cough. Additionally, these medications are mostly preferred to treat persistent dry coughs that don't produce mucus. The factors propelling the market include advances in drug development, changes in healthcare policies, the prevalence of respiratory conditions, and consumer preferences for over-the-counter or prescription medications.

• The market is divided into two categories based on the route of administration: inhalational, oral, and others. The oral segment is expected to hold the highest market share. It refers to a market assessment or analysis of a particular segment within the broader antitussive drugs market which are administered orally including tablets, lozenges, syrups, and capsules.

• The market is divided into three categories based on age group: geriatric, pediatric, and adult. The geriatric segment is anticipated to witness speedy growth. The term geriatric population refers to individuals 65 and older. This population has special healthcare needs and traits that have implications for several industries, such as pharmaceuticals and healthcare.

• The market is divided into three categories based on end-users: homecare, hospitals, specialty clinics, and others. The specialty clinics segment is likely to possess the largest market share. The segment focuses on selective medical specialties, including respiratory and pulmonology medicine. The clinics commonly engaged in clinical trials and research related to respiratory diseases. Additionally, this will assist in the testing and development of new antitussive drugs.

Antitussive Drugs Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Antitussive Drugs Market- Competitive Landscape:

Easy availability and rising awareness of these drugs will offer advantages for market growth. Moreover, the antitussive drugs market will boost as public and private organizations take initiatives to spread awareness. Rising infection cases of the upper respiratory tract and high disposable income will result in the expansion of the antitussive drugs business. An increase in the number of research and development activities will provide beneficial opportunities as well as rising drug launches and approvals will further propel the market's growth rate. For instance, in March 2021, Merck announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding Merck's New Drug Application (NDA) for gefapixant, the investigational, orally administered selective P2X3 receptor antagonist, non-narcotic under development for the unexplained chronic cough (UCC) or treatment of refractory chronic cough (RCC) in adults agency to discuss the next steps.

Recent Developments:

For instance, in September 2021, Sun Pharmaceutical Industries Ltd. launched of a novel formulation in cough management - Chericof 12 (chlorpheniramine maleate 4 mg or dextromethorphan hydrobromide 30 mg) in India.

Key features of the study:

• This proposed research study on antitussive drugs market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.

• The report provides the client the latest up-to-date and trending insights about the antitussive drugs market.

• The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for antitussive drugs market.

• The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the antitussive drugs market.

• Impact of COVID-19 on antitussive drugs market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on antitussive drugs market post-COVID will also be covered.

• In order to give the users of this report a comprehensive view on the antitussive drugs market, we have also included competitive landscape and key innovator analysis for the antitussive drugs market.

• The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

• The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the antitussive drugs market.

• In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

• The global antitussive drugs market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTITUSSIVE DRUGS MARKET KEY PLAYERS

• Teva Pharmaceutical Industries Ltd.
• Intas Pharmaceuticals Ltd.
• Bayer AG
• Aceto
• Sanofi
• Ipca Laboratories Ltd.
• 3M
• F. Hoffmann-La Roche Ltd.
• Hikma Pharmaceuticals PLC
• Unique Pharmaceuticals Limited
• Cipla Inc.
• Mylan N.V.
• Zydus Cadila
• Sanofi
• Novartis AG
• Aurobindo Pharma

GLOBAL ANTITUSSIVE DRUGS MARKET, BY DRUG CLASS

• Peripherally Acting Drugs
• Centrally Acting Drugs
• Others

GLOBAL ANTITUSSIVE DRUGS MARKET, BY ROUTE OF ADMINISTRATION

• Inhalational
• Oral
• Others

GLOBAL ANTITUSSIVE DRUGS MARKET, BY AGE GROUP

• Geriatric
• Pediatric
• Adult

GLOBAL ANTITUSSIVE DRUGS MARKET, BY END-USERS

• Homecare
• Hospitals
• Specialty Clinics
• Others

GLOBAL ANTITUSSIVE DRUGS MARKET, BY REGION

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Antitussive Drugs Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Antitussive Drugs Market Snippet by Drug Class
  • 2.1.2. Antitussive Drugs Market Snippet by Route of Administration
  • 2.1.3. Antitussive Drugs Market Snippet by Age Group
  • 2.1.4. Antitussive Drugs Market Snippet by End-Users
  • 2.1.5. Antitussive Drugs Market Snippet by Country
  • 2.1.6. Antitussive Drugs Market Snippet by Region
• 2.2. Competitive Insights

3. Antitussive Drugs Key Market Trends

• 3.1. Antitussive Drugs Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Antitussive Drugs Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Antitussive Drugs Market Opportunities
• 3.4. Antitussive Drugs Market Future Trends

4. Antitussive Drugs Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Antitussive Drugs Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Antitussive Drugs Market Landscape

• 6.1. Antitussive Drugs Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Antitussive Drugs Market - By Drug Class

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Drug Class, 2022&2030 (%)
  • 7.1.2. Peripherally Acting Drugs
  • 7.1.3. Centrally Acting Drugs
  • 7.1.4. Others

8. Antitussive Drugs Market - By Route of Administration

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Route of Administration, 2022&2030 (%)
  • 8.1.2. Inhalational
  • 8.1.3. Oral
  • 8.1.4. Others

9. Antitussive Drugs Market - By Age Group

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Age Group, 2022&2030 (%)
  • 9.1.2. Geriatric
  • 9.1.3. Pediatric
  • 9.1.4. Adult

10. Antitussive Drugs Market - By End-Users

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By End-Users, 2022&2030 (%)
  • 10.1.2. Homecare
  • 10.1.3. Hospitals
  • 10.1.4. Specialty Clinics
  • 10.1.5. Others

11. Antitussive Drugs Market- By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Antitussive Drugs Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Antitussive Drugs Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.3.9. Italy
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.9.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.9.5. Italy Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.3.9.6. Italy Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.3.10. United Kingdom
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.10.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.10.5. United Kingdom Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.3.10.6. United Kingdom Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.3.11. France
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.11.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.3.11.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.11.5. France Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.3.11.6. France Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.3.12. Russia
    • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.12.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.12.4. Russia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.3.12.5. Russia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.3.13. Netherlands
    • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.13.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.13.4. Netherlands Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.3.13.5. Netherlands Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.14.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.3.15. Poland
    • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.15.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.15.4. Poland Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.3.15.5. Poland Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.3.16. Rest of Europe
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Antitussive Drugs Key Manufacturers in Asia Pacific
  • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  • 11.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 11.4.6. Asia Pacific Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
  • 11.4.7. Asia Pacific Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.4.8. India
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.8.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.4.8.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.8.5. India Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.4.8.6. India Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.4.9. China
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.9.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.4.9.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.9.5. China Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.4.9.6. China Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.4.13. Thailand
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.13.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.4.13.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.13.5. Thailand Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.4.13.6. Thailand Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.4.14. Indonesia
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.14.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.4.14.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.14.5. Indonesia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.4.14.6. Indonesia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.4.16. Rest of APAC
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.16.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.16.5. Rest of APAC Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
• 11.5. Latin America
  • 11.5.1. Overview
  • 11.5.2. Antitussive Drugs Key Manufacturers in Latin America
  • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  • 11.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 11.5.6. Latin America Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
  • 11.5.7. Latin America Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
• 11.6. Middle East and Africa
  • 11.6.1. Overview
  • 11.6.2. Antitussive Drugs Key Manufacturers in Middle East and Africa
  • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  • 11.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 11.6.6. Middle East and Africa Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
  • 11.6.7. Middle East and Africa Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.6.14. Rest of MEA
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.14.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.14.5. Rest of MEA Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Antitussive Drugs Industry

• 12.1. Competitive Dashboard
• 12.2. Company Profiles
  • 12.2.1. Teva Pharmaceutical Industries Ltd.
  • 12.2.2. Intas Pharmaceuticals Ltd.
  • 12.2.3. Bayer AG
  • 12.2.4. Aceto
  • 12.2.5. Sanofi
  • 12.2.6. Ipca Laboratories Ltd.
  • 12.2.7. 3M
  • 12.2.8. F. Hoffmann-La Roche Ltd.
  • 12.2.9. Hikma Pharmaceuticals PLC
  • 12.2.10. Unique Pharmaceuticals Limited
  • 12.2.11. Cipla Inc.
  • 12.2.12. Mylan N.V.
  • 12.2.13. Zydus Cadila
  • 12.2.14. Sanofi
  • 12.2.15. Novartis AG
  • 12.2.16. Aurobindo Pharma

13. 360 Degree Analyst View

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us

관련자료